What is the main business of Apteka Polonez?

The main business activity of Apteka Polonez focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 11, 2004.

Where is the headquarters located?

The headquarters is located at: Aleje Jerozolimskie 134, 02-305 Warszawa.

What is the share capital?

The share capital of the company is PLN 3,100,000 (approx. $837,385).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $1,765,230 in 2024, which is a decrease of 12.2% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $49,993. For comparison, in 2023 the loss was $73,540, meaning the company reduced its loss by 35.4%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $1,376,571 in 2024, representing 78% of all operating expenses.

Apteka Polonezsp. z o.o.

Q: Who is on the management board?

The management board consists of: Rafał Emil Jarząbek (Vice President of the Management Board), Igor Wojciech Jachorski (President of the Management Board), and Paulina Świderek (Vice President of the Management Board).

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-08-11

Share capital

3 100 000,00 PLN

Registered address

Aleje Jerozolimskie 134, 02-305 Warszawa, Poland

Electronic delivery address

AE:PL-90803-33142-FVTWU-17

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 2.12mMedianUSD 1.76mAverageUSD 4.96m

Net profit

This companyUSD -43.38kMedianUSD 17.49kAverageUSD 77.31k

Operating costs

This companyUSD 2.11mMedianUSD 1.72mAverageUSD 4.80m

Assets

This companyUSD 3.93mMedianUSD 495.60kAverageUSD 1.69m

Industry

Bank accounts

Registered as a VAT taxpayer on 2004-08-18. Active

BNP Paribas Bank Polska
36 1750 0009 0000 0000 2361 4097
BNP Paribas Bank Polska
40 1750 0009 0000 0000 3924 1986
BNP Paribas Bank Polska
80 1600 1462 1085 4737 3000 0003

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Sep 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$2,281$2,281	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,163$3,163	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$2,356$2,356	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Rafał Emil Jarząbek — Vice President of the Management Board

Igor Wojciech Jachorski — President of the Management Board

Paulina Świderek — Vice President of the Management Board

Manner of representation

The company is represented by the President of the Management Board acting alone, or by two members of the management board acting jointly.

Ownership

Owner	Shares	Share value	Stake
Euro-Apteka sp. z o.o.	31,000	$837,385.20	100%

Beneficial owners

Person	Rights
Zbigniew Jacek Molenda (63)	„sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki”.
Jacek Romuald Szwajcowski (62)	„sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki”.

Subsidiaries

	Name	Share value	Stake
	Apteka 36,6sp. z o.o.	351,161.53 USD	100%

Competitors

Name	Revenue	Website
Cosmedicasp. z o.o.	$49,355,260.75	cosmedica.pl
DR ZdrowieS.A.	$40,415,498.47	drzdrowie.pl
MagmaxS.A.	$4,200,912.15	magmaxsa.pl
Novopharm - Millersp. j.	$2,839,228.36	apteka.zyj-zdrowo.com
MaglowS.A.	$1,356,219.12	maglow.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Nukloversp. z o.o.	$227,479.26	nuklover.com
Massmedsp. z o.o.	$49,747.70	mojoapps.co
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.	$2,740.83	kwendasa.pl
Femaherbsp. z o.o.	$655.76	femaherb.com

Change history

Date	Event
2021-12-13	Address change (Żytnia 15/17, 01-014, Warszawa → Aleje Jerozolimskie 134, 02-305, Warszawa)
2019-09-11	Share capital change (3,000,000.00 PLN → 3,100,000.00 PLN)
2015-05-12	PKD change (Removed: 21.10.Z, 32.50.Z, 41.10.Z, 46.15.Z, 46.16.Z, 46.17.Z, 46.19.Z, 46.45.Z, 46.46.Z, 46.65.Z, 46.66.Z, 46.75.Z, 46.90.Z, 52.24.A, 52.24.B, 52.24.C, 64.91.Z, 64.99.Z, 66.11.Z, 68.10.Z, 68.31.Z, 68.32.Z, 70.22.Z, 71.11.Z, 71.12.Z, 73.20.Z, 77.33.Z, 82.30.Z, 82.92.Z)
2009-12-23	PKD change (Removed: 24.41.Z, 24.42.Z, 51.15.Z, 51.16.Z, 51.17.Z, 51.19.Z, 51.45.Z, 51.46.Z, 51.55.Z, 51.90.Z, 52.12.Z, 52.27.B, 52.31.Z, 52.32.Z, 52.33.Z, 52.48.B, 63.11.A, 63.11.B, 63.11.C, 63.12.A, 63.12.B, 63.12.C, 65.21.Z, 65.23.Z, 67.11.Z, 70.11.Z, 70.12.Z, 70.20.Z, 70.31.Z, 70.32.Z, 71.33.Z, 74.13.Z, 74.14.A, 74.20.A, 74.40, 74.82.Z, 74.87.A; Added: 21.10.Z, 21.20.Z, 32.50.Z, 41.10.Z, 46.15.Z, 46.16.Z, 46.17.Z, 46.19.Z, 46.45.Z, 46.46.Z, 46.65.Z, 46.66.Z, 46.75.Z, 46.90.Z, 47.19.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.78.Z, 52.10.B, 52.24.A, 52.24.B, 52.24.C, 64.91.Z, 64.99.Z, 66.11.Z, 68.10.Z, 68.20.Z, 68.31.Z, 68.32.Z, 70.22.Z, 71.11.Z, 71.12.Z, 73.11.Z, 73.20.Z, 77.33.Z, 82.30.Z, 82.92.Z)
2006-11-30	Address change (Obozowa 20, 01-161, Warszawa → Żytnia 15/17, 01-014, Warszawa)

FAQ

Last updated: 2026-06-21